{"filing":{"accession_number":"0001628280-26-046247","cik":"0001756655","ticker":"ARDT","company_name":"Ardent Health, Inc.","form":"8-K","filing_date":"2026-06-30","report_date":null,"primary_document":"ardt-20260626.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1756655/000162828026046247/ardt-20260626.htm"},"events":[{"id":15159,"run_id":13529,"accession_number":"0001628280-26-046247","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"Martin J. Bonick departed from his role as President and Chief Executive Officer and stepped down from the Board effective June 2, 2026. While the disclosure also addresses severance benefits and a separation agreement, the principal disclosed action is the departure of the CEO and board member. The severance terms are ancillary to the core event of executive departure.","company_name":"Ardent Health, Inc.","ticker":"ARDT","filing_date":"2026-06-30","form":"8-K","submitted_at":null,"items":[{"id":12823,"accession_number":"0001628280-26-046247","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"Martin J. Bonick departed from his role as President and Chief Executive Officer and stepped down from the Board effective June 2, 2026. While the disclosure also addresses severance benefits and a separation agreement, the principal disclosed action is the departure of the CEO and board member. The severance terms are ancillary to the core event of executive departure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-01T11:16:12.669632+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":12823,"accession_number":"0001628280-26-046247","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"Martin J. Bonick departed from his role as President and Chief Executive Officer and stepped down from the Board effective June 2, 2026. While the disclosure also addresses severance benefits and a separation agreement, the principal disclosed action is the departure of the CEO and board member. The severance terms are ancillary to the core event of executive departure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-01T11:16:12.669632+00:00","company_name":"Ardent Health, Inc.","ticker":"ARDT","filing_date":"2026-06-30"}]}